Outcome of Brolucizumab-dbll and Aflibercept Intravitreal Injection in the Treatment of Diabetic Macular Edema
Latest Information Update: 06 Jul 2023
At a glance
- Drugs Brolucizumab (Primary) ; Aflibercept
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 13 Jul 2021 New trial record